TREM ‐1 Pathway Biomarkers for Classification of Periodontal Diseases and Monitoring of Treatment Response in Grade B and C Periodontitis
Journal of Clinical Periodontology · 2025
DOI: 10.1111/jcpe.14195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Periodontology, 2025. Verfasst von Angelika Silbereisen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oral Health and Periodontology, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Triggering Receptor Expressed on Myeloid Cells-1, Periodontitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Vetenskapsrådet, Steering Group KI/Region Stockholm for Dental Research, Karolinska Institutet's Strategic Funds.
Abstract (Originalsprache)
Background
This study investigated the diagnostic potential of salivary triggering receptor expressed on myeloid cells (TREM)‐1, peptidoglycan recognition protein 1 (PGLYRP1) and interleukin (IL)‐1β for periodontitis patients and their ability to predict treatment outcome.
Methods
Systemically healthy, non‐smokers with gingivitis ( n = 31), stage III periodontitis (34 grade B: n = 34, grade C: n = 24) and healthy controls ( n = 34) were recruited. Periodontitis patients ( n = 42) underwent non‐surgical periodontal treatment. Saliva was collected at baseline (T0) and post‐treatment (T1, T3, T6). Biomarkers were measured using immunoassays. Periodontitis patients were categorised into responders ( n = 19) and non‐responders ( n = 23) based on the number of residual pockets ≥ 5 mm with bleeding on probing at T6.
Results
TREM‐1 was higher in periodontitis than in gingivitis and health, and in periodontitis grade B than in gingivitis ( p < 0.05). PGLYRP1 and IL‐1β were higher in periodontitis and gingivitis compared to controls ( p < 0.01). All biomarkers discriminated periodontitis from health (AUC ≥ 0.9) with high sensitivity (82.1%–92.8%) and specificity (83.3%–88.9%). TREM‐1 differentiated periodontitis from gingivitis (AUC = 0.72) with high sensitivity (92.8%) but low specificity (58.1%). Baseline biomarkers did not predict treatment outcome (AUC ≤ 0.61), while T1 levels showed moderate potential (AUC ≥ 0.71).
Conclusions
Salivary TREM‐1 pathway biomarkers offer diagnostic value for periodontitis, are modulated by therapy but show limited ability to predict treatment outcome. Study Registration The study has been registered in ClinicalTrials.gov (ID: NCT06715176, 4 December 2024).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oral Health and Periodontology, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Division of Oral Diagnostics and Surgery, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Periodontology, Faculty of Dentistry, Aydın Adnan Menderes University, Aydın, Turkey.
- Department of Periodontology, School of Dentistry, İstinye University, Istanbul, Turkey.
ORCID-Profile: Angelika Silbereisen, Ronaldo Lira-Junior, Nagihan Bostanci
Förderung
- Vetenskapsrådet
- Steering Group KI/Region Stockholm for Dental Research
- Karolinska Institutet's Strategic Funds
Zitieren
APA
Silbereisen, A., Lira-Junior, R., Afacan, B., Özturk, O. V., Emingil, G., & Bostanci, N. (2025). TREM ‐1 Pathway Biomarkers for Classification of Periodontal Diseases and Monitoring of Treatment Response in Grade B and C Periodontitis. Journal of Clinical Periodontology. https://doi.org/10.1111/jcpe.14195
Vancouver
Silbereisen A, Lira-Junior R, Afacan B, Özturk OV, Emingil G, Bostanci N. TREM ‐1 Pathway Biomarkers for Classification of Periodontal Diseases and Monitoring of Treatment Response in Grade B and C Periodontitis. Journal of Clinical Periodontology. 2025. doi:10.1111/jcpe.14195
BibTeX
@article{Silbereisen2025,
author = {Silbereisen, Angelika and Lira-Junior, Ronaldo and Afacan, Beral and Özturk, Ozgen-Veli and Emingil, Gülnur and Bostanci, Nagihan},
title = {TREM ‐1 Pathway Biomarkers for Classification of Periodontal Diseases and Monitoring of Treatment Response in Grade B and C Periodontitis},
journal = {Journal of Clinical Periodontology},
year = {2025},
doi = {10.1111/jcpe.14195}
}
EUVIMED